Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma

Yu, Xinshuang; Zhang, Jiandong; Zhong, Hua; Liu, Fengjun; Liang, Ning; Wang, Yao; Meng, Xiangjiao; Du, Juan

doi:10.7150/ijms.16381



Theranostics

International Journal of Biological Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Med Sci 2016; 13(12):963-969. doi:10.7150/ijms.16381 This issue Cite

Research Paper

Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma

Xinshuang Yu¹, Jiandong Zhang¹, Hua Zhong^3,5, Fengjun Liu¹, Ning Liang¹, Yao Wang², Xiangjiao Meng⁴, Juan Du^1,2✉

1. Department of Radiation Oncology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan 250014, P. R.China.
2. Medical Research Center, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, 250014, P. R.China.
3. Department of Traditional Chinese Medicine, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, 250014, P. R.China.
4. Department of Radiation Oncology, Shandong Cancer Hospital, Jinan, 250117, P. R.China.
5. Department of Oncology, Shandong University of Traditional Chinese Medicine Jinan, 250355, P. R.China.

Citation:

Yu X, Zhang J, Zhong H, Liu F, Liang N, Wang Y, Meng X, Du J. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma. Int J Med Sci 2016; 13(12):963-969. doi:10.7150/ijms.16381. https://www.medsci.org/v13p0963.htm

Other styles

Abstract

TUSC3 was recently identified as a potential tumor suppressor gene in a variety of human malignancies. However, no data are currently available regarding the expressions of TUSC3 in esophageal cancer (ESCC).The purposes of this study was to investigated the expressions of TUSC3 in ESCC tissues and assess the relationship between TUSC3 levels and clinico-pathological characteristics of ESCC patients. TUSC3 protein expressions were evaluated by immunohistochemistry (IHC) on tissue microarray slides in esophageal cancer, which included 95 esophageal squamous carcinoma specimens (ESCC), and 75 normal esophageal mucosa (NEM). We found that TUSC3 in ESCC was significant lower than that in NEM (P=0.000). According to multi-clinical classifications, TUSC3 level varied significantly with TNM stage, T stage, and N stage (p<0.001, p=0.0368, p<0.0001, respectively). Univariate analysis showed that gender, TNM stage, T stage, N stage, TUSC3 expression were prognostic factors for survival. Multivariate analysis showed that in our study, only TUSC3 expression was independent prognostic factors for ESCC. Our results indicated for the first time, a combined analysis of TUSC3 expressions as well as the clinical variables will help predict the prognosis of ESCC patients. Further large-sample validation and functional analysis should be performed to evaluate its potential prognostic and therapeutic values for ESCC patients.

Keywords: Tumor suppressor candidate 3 (TUSC3), Esophageal squamous cell carcinoma (ESCC), Biomarker, Overall survival (OS), Prognosis.

Citation styles

APA

Yu, X., Zhang, J., Zhong, H., Liu, F., Liang, N., Wang, Y., Meng, X., Du, J. (2016). Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma. International Journal of Medical Sciences, 13(12), 963-969. https://doi.org/10.7150/ijms.16381.

ACS

Yu, X.; Zhang, J.; Zhong, H.; Liu, F.; Liang, N.; Wang, Y.; Meng, X.; Du, J. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma. Int. J. Med. Sci. 2016, 13 (12), 963-969. DOI: 10.7150/ijms.16381.

NLM

CSE

Yu X, Zhang J, Zhong H, Liu F, Liang N, Wang Y, Meng X, Du J. 2016. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma. Int J Med Sci. 13(12):963-969.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.